LFMD vs. SMED, RGS, MRM, AIH, FLGT, CELC, SHCR, AUNA, EHAB, and GRAL
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Sharps Compliance (SMED), Regis (RGS), MEDIROM Healthcare Technologies (MRM), Aesthetic Medical International Holdings Group (AIH), Fulgent Genetics (FLGT), Celcuity (CELC), Sharecare (SHCR), Auna (AUNA), Enhabit (EHAB), and Grail (GRAL).
Sharps Compliance (NASDAQ:SMED) and LifeMD (NASDAQ:LFMD) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, community ranking, risk, profitability, media sentiment, valuation and dividends.
Sharps Compliance has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.
In the previous week, LifeMD had 5 more articles in the media than Sharps Compliance. MarketBeat recorded 5 mentions for LifeMD and 0 mentions for Sharps Compliance. LifeMD's average media sentiment score of 1.45 beat Sharps Compliance's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.
Sharps Compliance has a net margin of 7.88% compared to LifeMD's net margin of -13.62%. Sharps Compliance's return on equity of 5.48% beat LifeMD's return on equity.
Sharps Compliance has higher earnings, but lower revenue than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Sharps Compliance, indicating that it is currently the more affordable of the two stocks.
LifeMD has a consensus price target of $12.00, suggesting a potential upside of 127.70%. Given LifeMD's higher probable upside, analysts plainly believe LifeMD is more favorable than Sharps Compliance.
56.1% of Sharps Compliance shares are owned by institutional investors. Comparatively, 35.5% of LifeMD shares are owned by institutional investors. 4.8% of Sharps Compliance shares are owned by insiders. Comparatively, 18.9% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Sharps Compliance received 209 more outperform votes than LifeMD when rated by MarketBeat users. However, 74.42% of users gave LifeMD an outperform vote while only 50.42% of users gave Sharps Compliance an outperform vote.
Summary
Sharps Compliance beats LifeMD on 10 of the 17 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
